Libya Achieves Landmark Trachoma Elimination, Marking a Major Public Health Victory Amidst Adversity

The World Health Organization (WHO) has officially announced that Libya has successfully eliminated trachoma as a public health problem, a monumental achievement that resonates deeply within the WHO’s Eastern Mediterranean Region and the global public health community. This hard-won victory not only safeguards future generations of Libyans from preventable blindness but also serves as a potent reminder that even countries grappling with significant challenges can overcome neglected tropical diseases (NTDs). The validation underscores the power of sustained national commitment, strategic international partnership, and the resilience of health systems, even in adverse circumstances.

This significant milestone positions Libya as the 28th country globally and the 8th in the Eastern Mediterranean Region to achieve trachoma elimination. The accomplishment is particularly inspiring given the complex humanitarian and migration dynamics that have characterized Libya in recent years, demonstrating that evidence-based programming and coordinated technical support can indeed triumph over persistent health obstacles. Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, lauded the achievement, stating, "This milestone reflects Libya’s determination to safeguard the health of its people and reinforces our conviction that progress against neglected tropical diseases is possible everywhere. Eliminating trachoma as a public health problem is an inspiring achievement for the Eastern Mediterranean Region and for communities across Libya." His sentiment was echoed by Dr. Hanan Balkhy, WHO Regional Director for the Eastern Mediterranean, who remarked, "Libya joins a growing group of countries from the Eastern Mediterranean Region that have eliminated trachoma. This result reflects strong regional coordination and Libya’s perseverance during periods of great challenge."

A Century-Long Battle: Trachoma’s Enduring Legacy in Libya

Trachoma, a highly contagious bacterial infection caused by Chlamydia trachomatis, has cast a long shadow over Libya’s public health landscape for well over a century. Historical records from the 20th century consistently documented high levels of active (inflammatory) trachoma across numerous communities, with the southern regions of the country bearing a disproportionately heavy burden. The disease is primarily spread through direct contact with infected eye and nose discharges, often via hands, clothing, or even flies, particularly in environments with limited access to clean water, adequate sanitation, and proper hygiene. Repeated infections over many years lead to scarring of the inner eyelid, a condition known as trachomatous trichiasis, where the eyelashes turn inward and painfully scratch the cornea. If left untreated, this constant irritation can lead to irreversible corneal opacities and permanent blindness, trapping individuals and communities in a devastating cycle of poverty and disability.

The profound impact of trachoma extends far beyond individual suffering. It severely limits productivity, hindering economic development and perpetuating cycles of disadvantage within affected families and regions. Children afflicted with active trachoma often struggle with schooling, while adults, particularly women who are disproportionately affected by trichiasis, lose their ability to work and care for their families, further straining household resources and community resilience. The sheer scale of the historical problem meant that early efforts to combat infectious eye diseases in Libya were critical but faced immense challenges.

Decades of Dedication: Libya’s Path to Elimination

Libya’s journey towards trachoma elimination is a testament to decades of persistent effort, evolving public health strategies, and unwavering commitment. Initial significant strides were made by the Ministry of Health in the 1970s and 1980s, when concerted campaigns were launched to control infectious eye diseases. These early initiatives likely involved mass treatment campaigns with antibiotics, community awareness programs on hygiene, and the establishment of basic eye care services. Following these foundational efforts and subsequent broader health system strengthening across the nation, subsequent surveys indicated a dramatic decline in trachoma transmission, a clear sign that the public health interventions were yielding positive results.

The modern phase of Libya’s elimination strategy gained renewed momentum in 2017 when the Ministry of Health formally prioritized trachoma elimination as an integral component of its national eye health work, embedded within the broader National Prevention of Blindness Programme. This strategic alignment ensured that resources and attention were channeled effectively towards the goal. The global standard for trachoma control and elimination is the WHO-endorsed SAFE strategy: Surgery for trichiasis, Antibiotics to treat active infection, Facial cleanliness, and Environmental improvements to reduce transmission. While not explicitly detailed in the original brief, it can be inferred that Libya’s program incorporated elements of this comprehensive approach.

With crucial technical and operational support from international partners including the WHO, Sightsavers, the International Trachoma Initiative (ITI), and Tropical Data, targeted surveys were meticulously planned and executed in 2022. These surveys focused specifically on six southern districts where trachoma was historically prevalent and suspected to persist. The findings were largely positive, revealing that the prevalence of active trachoma and trichiasis was below the WHO elimination thresholds in most areas. However, a critical pocket of concern was identified in Wadi Al Hayaa/Ghat, where the prevalence of trichiasis still exceeded the benchmark. This precise data allowed for a highly targeted and effective intervention: a dedicated trichiasis surgery campaign was immediately launched in these specific areas, providing sight-saving operations to those suffering from the advanced, blinding stage of the disease. The success of this focused effort was confirmed by a subsequent survey conducted in 2025, which conclusively demonstrated that the prevalence of trichiasis had fallen below WHO’s elimination threshold across the entire country, thus validating Libya’s achievement.

Resilience in the Face of Crisis: Triumph Amidst Instability

What makes Libya’s accomplishment particularly remarkable is the backdrop against which it was achieved: years of profound political instability, civil conflict, and complex humanitarian challenges. These adversities have severely strained the nation’s health services, led to significant population displacement, and dramatically increased the demand for basic services, including access to safe water, sanitation, and hygiene facilities—all critical factors in trachoma prevention.

During periods of conflict, health infrastructure is often damaged or destroyed, supply chains for essential medicines and equipment are disrupted, and skilled health workers may be displaced or unable to reach affected populations due to insecurity. The focus of health systems in such environments typically shifts towards emergency response and acute care, making sustained, long-term public health programs like disease elimination campaigns incredibly difficult to maintain. Despite these formidable pressures, Libya’s national trachoma elimination programme not only persevered but thrived. Its success is a testament to its strategic integration of surveillance activities, the expanded access to vital surgical care for trichiasis, the dedicated capacity-building initiatives for eye health workers, and the crucial collaborative partnerships forged with both national and international stakeholders.

Dr. Mohamed Al-Ghoj, Libya’s Acting Minister of Health, proudly articulated this triumph over adversity: "This validation is a source of pride for Libya and a testament to the commitment of our health workers and communities. Even through difficult years, we maintained our focus on improving eye health services and ensuring no one was left behind. This success would not have been possible without the professionalism and dedication of our doctors, nurses and health workers in the field who reached all and every district to ensure a future free of preventable blindness." The enduring commitment of these frontline health workers, often operating in challenging and insecure environments, underscores the human element at the heart of this public health victory.

The WHO Country Office in Libya played an indispensable role throughout these challenging years, providing extensive technical and operational support. This assistance was crucial in bolstering national capacities to prevent, detect, and control diseases, ultimately ensuring the highest attainable standards of health and well-being for the Libyan populace. Dr. Ahmed Zouiten, WHO Representative in Libya, emphasized the collaborative spirit, stating, "Reaching trachoma elimination status in Libya is a testimony of what could be achieved when the Ministry of Health teams and the WHO teams deliver as one. It is a collective public health triumph achieved through science, national mobilization and international solidarity." This collaborative model, fusing local expertise with global support, proved instrumental in navigating the complexities of the Libyan context.

A Global Perspective: The Fight Against Neglected Tropical Diseases

Libya’s victory against trachoma must be viewed within the broader global effort to eradicate Neglected Tropical Diseases (NTDs). Trachoma, while eliminated in Libya, remains endemic in numerous vulnerable communities worldwide, predominantly where poverty, limited access to clean water, and inadequate sanitation perpetuate its spread. Globally, an estimated 1.9 million people are blind or visually impaired due to trachoma, with millions more suffering from trichiasis, disproportionately affecting women and children.

In 1996, recognizing the immense global burden of trachoma, the WHO launched the WHO Alliance for the Global Elimination of Trachoma by 2020 (GET2020). This ambitious initiative forged a powerful network of governments, non-governmental organizations, academic institutions, and pharmaceutical companies, all committed to the common goal of eliminating trachoma as a public health problem. The GET2020 alliance championed the SAFE strategy, advocating for its widespread implementation in endemic countries. While the initial target year of 2020 has passed, the momentum has continued, with countries like Libya demonstrating that sustained efforts can indeed lead to elimination. The WHO continues to actively support endemic nations, providing technical guidance, resources, and coordination to accelerate progress towards the global goal.

Neglected Tropical Diseases are a diverse group of 21 debilitating conditions that collectively affect over one billion people globally. These diseases are termed "neglected" because they disproportionately impact impoverished communities in tropical and subtropical regions, often receiving less attention and funding compared to other major health issues. They are associated with devastating health, social, and economic consequences, trapping individuals and communities in a vicious cycle of poverty and disease. The WHO’s "Roadmap for Neglected Tropical Diseases 2021–2030" outlines ambitious public health targets for the control, elimination, and eradication of these conditions, aiming for a world free from their burden.

Libya’s achievement contributes significantly to these global targets. In 2025 alone, nine countries received validation, verification, or certification from WHO for achieving their NTD targets. Following the validation of trachoma elimination, Libya now stands as the 59th country globally and the 10th in the Eastern Mediterranean Region to have eliminated at least one neglected tropical disease. This demonstrates a growing global commitment and capacity to tackle these historically overlooked diseases, proving that with political will, sustained funding, and collaborative action, the suffering caused by NTDs can be alleviated.

The Ripple Effect: Socio-Economic Impact and Future Outlook

The elimination of trachoma in Libya carries profound socio-economic implications. By preventing blindness and visual impairment, the country can expect to see increased productivity, improved educational outcomes for children, and greater participation in community life. Individuals who might otherwise have suffered from debilitating eye conditions are now free to contribute fully to society, fostering economic growth and social development. The reduction in healthcare costs associated with treating advanced trachoma and managing blindness also frees up valuable resources that can be redirected to other pressing public health priorities.

Moreover, Libya’s success serves as an inspiring blueprint for other countries in the Eastern Mediterranean Region and beyond, especially those grappling with similar challenges of instability and resource constraints. It demonstrates that integrating disease elimination programs within broader health system strengthening efforts, even amidst adversity, is not only possible but highly effective. The rigorous surveillance systems established for trachoma can now be leveraged for other public health concerns, creating a stronger, more resilient health infrastructure.

Looking ahead, the challenge for Libya, like all countries that achieve elimination status, will be to maintain vigilance. Sustained surveillance systems are crucial to detect any potential re-emergence of the disease, particularly in areas with ongoing population movement or where access to water and sanitation remains a challenge. Continued investment in primary healthcare, improved water infrastructure, and enhanced hygiene promotion will be essential to ensure that trachoma remains a disease of the past in Libya. This landmark achievement not only celebrates a victory against a ancient scourge but also reaffirms the enduring power of public health interventions to transform lives and build healthier, more prosperous societies.